We first examined the modulation of breast cancer cell survival in the presence of IGF-I, IGF-II, FGF-2 or EGF, and we confirmed that, except for EGF, these growth factors promoted MCF-7 and T47D cell survival in vitro under serum-free conditions. Here, IGF2 is linked to breast cancer.